166 results on '"Mok, A."'
Search Results
2. Fear of recurrence, emotional well-being and quality of life among long-term advanced ovarian cancer survivors
3. Poor survival with wild-type TP53 ovarian cancer?
4. The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma
5. Up-regulation of stromal versican expression in advanced stage serous ovarian cancer
6. Clear cell ovarian tumors display a unique tumor immune microenvironment
7. Identification of an exosomal-derived biomarker signature for early detection of ovarian cancer in BRCA mutation carriers (033)
8. Clear cell ovarian tumors display a unique tumor immune microenvironment
9. Differential immune landscapes in high-grade serous ovarian tumors of high-risk patients seen by imaging mass cytometry
10. Identification of a novel biomarker response in a prospective clinical trial of immune checkpoint blockade in high-grade serous ovarian carcinoma
11. Development of novel biomarkers for early detection of high-grade serous ovarian cancer in high-risk women using exosomal miRNAs
12. Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker
13. Comparative study of laparoscopico-vaginal radical hysterectomy and abdominal radical hysterectomy in patients with early cervical cancer
14. Development of novel biomarkers for early detection of high-grade serous ovarian cancer in high-risk women using exosomal miRNAs
15. Differential immune landscapes in high-grade serous ovarian tumors of high-risk patients seen by imaging mass cytometry
16. Identification of a novel biomarker response in a prospective clinical trial of immune checkpoint blockade in high-grade serous ovarian carcinoma
17. Osteopontin is down-regulated in hydatidiform mole
18. Protein profiling of complete mole and normal placenta using ProteinChip analysis on laser capture microdissected cells
19. Tumor associated macrophages (TAMs) mediate the oncogenic effect of fibroblast growth factor -18 (FGF18) in ovarian cancer
20. Lymphocyte-specific protein tyrosine kinase expression predicts survival in ovarian high-grade serous carcinoma
21. Tumor associated macrophages (TAMs) mediate the oncogenic effect of fibroblast growth factor -18 (FGF18) in ovarian cancer
22. Lymphocyte-specific protein tyrosine kinase expression predicts survival in ovarian high-grade serous carcinoma
23. Lysophospholipids Increase Interleukin-8 Expression in Ovarian Cancer Cells
24. Differential Expression of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 Protein and mRNA in Epithelial Ovarian Tumors
25. Expression of Epidermal Growth Factor Receptor-Related Family Products in Gestational Trophoblastic Diseases and Normal Placenta and Its Relationship with Development of Postmolar Tumor
26. ras Gene Activation and Infrequent Mutation in Papillary Serous Carcinoma of the Peritoneum
27. Genetic Alterations of the WT1 Gene in Papillary Serous Carcinoma of the Peritoneum
28. Differential Gene Expression Pattern between Normal Human Trophoblast and Choriocarcinoma Cell Lines: Downregulation of Heat Shock Protein-27 in Choriocarcinoma in Vitro and in Vivo
29. Matrix Metalloproteinases and Their Inhibitors in Gestational Trophoblastic Diseases and Normal Placenta
30. The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma
31. Up-regulation of stromal versican expression in advanced stage serous ovarian cancer
32. RUNX3 protein is overexpressed in human epithelial ovarian cancer
33. Overexpression of CEACAM6 in borderline and invasive mucinous ovarian neoplasms
34. Overexpression of laminin receptor 1 on decidual cells in partial and complete mole
35. Is the immune microenvironment of microsatellite instable endometrial cancer altered in morbidly obese vs non-obese patients?
36. Immune cell profiling in normal pregnancy, partial and complete molar pregnancy
37. Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinoma
38. Clusterin confers paclitaxel resistance in cervical cancer
39. Potential markers that complement expression of CA125 in epithelial ovarian cancer
40. Protein profiling of complete mole and normal placenta using ProteinChip analysis on laser capture microdissected cells☆☆The authors have no connection to any companies or products mentioned in this article
41. Is the immune microenvironment of microsatellite instable endometrial cancer altered in morbidly obese vs non-obese patients?
42. Lysophospholipids Increase Interleukin-8 Expression in Ovarian Cancer Cells
43. Differential Expression of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 Protein and mRNA in Epithelial Ovarian Tumors
44. ras Gene Activation and Infrequent Mutation in Papillary Serous Carcinoma of the Peritoneum
45. Differential Gene Expression Pattern between Normal Human Trophoblast and Choriocarcinoma Cell Lines: Downregulation of Heat Shock Protein-27 in Choriocarcinoma in Vitro and in Vivo
46. Matrix Metalloproteinases and Their Inhibitors in Gestational Trophoblastic Diseases and Normal Placenta
47. Endometrial cancer subtypes and immunotherapy: Is the immune microenvironment different in microsatellite instable endometrial cancer?
48. Poor survival with wild-type TP53 ovarian cancer?
49. Endometrial cancer subtypes and immunotherapy: Is the immune microenvironment different in microsatellite instable endometrial cancer?
50. Molecular Cloning of Differentially Expressed Genes in Human Epithelial Ovarian Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.